NEW YORK, Sept. 30, 2013 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) (“NeoStem” or the “Company”), a leader in the emerging cellular therapy industry, announced today that the Company and its subsidiary, Progenitor Cell Therapy (“PCT”), will present at multiple upcoming conferences in October.
Help employers find you! Check out all the jobs and post your resume.
